The Phantom Limb Pain Protocol

The Phantom Limb Pain Protocol—FDA and IRB-approved. We have begun subject accrual for what we believe to be of great benefit to those suffering from the physical and emotional aftermaths of trauma and amputations. Our goal is to establish the protocol for application worldwide. 

Ketamine has indications for potential benefit for a variety of pain disorders, including phantom limb pain. Based on a compelling anecdote (our story appearing in Lucid News), we are conducting a proof-of-concept study to assess ketamine’s potential benefit for this syndrome, which causes so much suffering. 

We are pleased to report that in October of 2025, we received FDA and IRB approval for our study. The study will be conducted at 4 sites, with the goal of assessing and treating 30 patients over a 6-month period and providing a 12-month follow-up.